BlueRidge Life Sciences Pharmaceutical Commercialization’s Dr. Naomi Sacks’s work published in Obesity Science & Practice on behalf of The Obesity Society was recently… read more
Author Archives: ricknelson
ToxStrategies Welcomes Brent Finley, Ph.D., DABT
ToxStrategies is pleased to announce that nationally recognized toxicologist Dr. Brent Finley has joined our firm as an Executive Vice President. Dr. Finley… read more
ToxStrategies is ready to support compliance with new cosmetics regulations
The first substantial changes to FDA’s regulatory authority over cosmetics makers and products since 1938 passed Congress in December 2022, in the form… read more
New study of aspartame and cancer finds no connection
A new article published in the journal Food and Chemical Toxicology concludes that the totality of evidence does not support a link between… read more
Scott Hawks to speak at annual pet food conference
For the 16th year, the American Feed Industry Association will hold its AFIA Pet Food Conference in conjunction with the 2023 International Production… read more
New article advances efforts to reduce animal toxicity testing
ToxStrategies scientists Drs. Allison Franzen and Susan Borghoff are among the authors of a new paper in the journal Critical Reviews in Toxicology…. read more
ToxStrategies at SETAC 2022
ToxStrategies scientists publish systematic mapping of cannabidiol (CBD) safety data
ToxStrategies scientists Dr. Rayetta Henderson, Kara Franke, Lauren Payne, and Dr. Allison Franzen have published an article titled, “Cannabidiol Safety Data: A Systematic Mapping Study” in Cannabis and Cannabinoid Research. This study is the first systematic map of the safety-related information available for CBD in the peer-reviewed literature and is part of an ongoing effort to establish a foundation for future research initiatives to support the determination of a safe CBD intake level for consumer use. The objective was to systematically map the publicly available safety-related literature for CBD, to provide a comprehensive overview of the current state of knowledge, assist in identifying data gaps and trends, and inform future hazard-based decision making. Available evidence was gathered and collated to demonstrate the current landscape of studies that report health outcomes to inform safety evaluation, as well as to identify outcomes or other subtopics that may warrant further research.